Search Results

Containing any of the words

Only of the type

Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies Drug Clinical Trial

An open-label, controlled, multi-site, Phase 2 clinical trial to assess the ureagenesis capacity in newborns and infants up to the age of 12 months with neonatal and infantile onset of urea cycle disorders (UCD) using a 15N ammonium chloride tracer compared to newborns and infants without UCD Drug Clinical Trial

Effect of interleukin-6 receptor inhibition with Tocilizumab in patients with rheumatoid arthritis Awareness Article

AN OPEN-LABEL STUDY IN PEDIATRIC (<18 YEARS OF AGE), SEVERE HEMOPHILIA A PARTICIPANTS (COAGULATION FACTOR ACTIVITY <1%) WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY ≤2%) WITH OR WITHOUT INHIBITORS COMPARING 12 MONTHS OF HISTORICAL STANDARD TREATMENT TO MARSTACIMAB PROPHYLAXIS Drug Clinical Trial

SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1) News

Early administration of Tocilizumab in Immunocompromised and potential high-risk patients for developing COVID-19 Drug Clinical Trial

(SG-2001-180-H) Potential risks due to difficulty or inability to deflate the balloon Medical Report

SFDA Chairs Arab Meeting, Discussing Plan to Study 25 Draft of Arab Standards for Medical Devices and Supplies News

(SG-2110-359-H) PACEMAKERS-Potential for Moisture to Enter the Pulse Generator Header Medical Report

(SG-2112-371-H) Potential of toxicological risks to patient Medical Report